|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.05 USD | -1.28% |
|
+7.21% | - |
| 07-13 | BofA Securities Adjusts Alamar Biosciences Price Target to $30 From $27 | MT |
| 07-13 | Alamar Biosciences Partners With Research Universities on Neurodegenerative Biomarker Project | MT |
Evolution of the Average Target: Alamar Biosciences, Inc.
Evolution of the Target Price: Alamar Biosciences, Inc.
Changes in Analyst Recommendations: Alamar Biosciences, Inc.
49c825d3adf5a4b1baf5d300c0d.moGrzsh9_CRhialmkslphC9LEDgy01rDgPFUMWDs4c8._8Lihb0zymAHzv4UpI0CwVg5XHZ6nhWlubAuBBO0tp_c5dz6uh7NXCy42g~2d7128318a7b6dbd577049e4d2882ae8
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +13.12% | |||||
| +10.71% | |||||
| +45.76% | |||||
| +21.84% | |||||
| +70.43% | |||||
| +9.59% | |||||
| +34.59% | |||||
| +17.84% | |||||
| +9.51% | |||||
| +27.61% | |||||
| Average | +26.10% | |||||
| Weighted average by Cap. | +26.64% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
27.05USD
Average target price
30.60USD
Spread / Average Target
+13.12%
High Price Target
35.00USD
Spread / Highest target
+29.39%
Low Price Target
28.00USD
Spread / Lowest Target
+3.51%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| BofA Securities | |
| Leerink Partners | |
| TD Cowen | |
| JPMorgan Chase | |
| Stifel Nicolaus |
SellBuy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
27.05USD
Average target price
30.60USD
Spread / Average Target
+13.12%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALMR Stock
- Consensus Alamar Biosciences, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
